The Molbio team embraces tradition with Dussehra festivities.
Their relentless pursuit of excellence drives transformative diagnostics and healthcare solutions that redefine possibilities, empowering us to impact lives globally and sustainably. Our team’s dedication, creativity, and collaborative spirit fuel the breakthroughs that shape tomorrow. They don’t just adapt to change—they lead it, ensuring Molbio remains a trailblazer in diagnostics and a trusted partner for healthcare professionals worldwide. Together, we are creating a healthier future, one groundbreaking solution at a time.
Connect with us
Molbio Diagnostics Limited
(Formerly Molbio Diagnostics Private Limited)
© All Rights Reserved
Sriram Natarajan is the Founder, Executive Director, and Chief Executive Officer of Molbio.
With a bachelor’s degree in science (botany) from the University of Delhi and a master’s in plant physiology from Tamil Nadu Agricultural University, he brings over 35 years of expertise in developing, manufacturing, and marketing diagnostic devices and kits for both domestic and international markets.
A visionary leader, Mr. Natarajan has been at the forefront of healthcare innovation, transforming diagnostics into a tool for global impact.
Dr. Chandrasekhar Nair is an Executive Director and Chief Technology Officer of Molbio. A scientist by training, Dr. Nair holds a Doctor of Philosophy in BioSciences from Vellore Institute of Technology University and leads Bigtec- the dedicated research and development wing of Molbio.
With over three decades of experience in translational research and development, leading multidisciplinary teams to develop various products,Molbio’s groundbreaking technology, Truenat- an ultra-portable, chip-based PCR (Polymerase Chain Reaction) system- is the brainchild of Dr. Nair and his team He is the recipient of the prestigious Infosys Prize 2021 in engineering and computer science, an acknowledgment of his invaluable contributions to innovation.
Sangeetha Sriram, Executive Director and Director of Operations at Molbio holds a bachelor’s degree in science from Sri Venkateswara University and a master’s degree in botany from the University of Delhi.
Her hands-on leadership ensures operational excellence in the manufacturing and production lines of Molbio, reflecting her commitment to advancing healthcare solutions.
With a sharp focus on partnerships and growth opportunities, Mr. Shiva Sriram is the President of Business Development and has been at the forefront of driving strategies to expand Molbio’s reach and impact.
With a graduate degree in biochemistry and a master’s in biochemical engineering from University College London, Shiva has over six years of experience in the diagnostics sector.
Dr. Kuldeep Singh Sachdeva is the President and Chief Medical Officer of Molbio and joined the organization on January 1, 2024. Dr. Sachdeva holds a medical degree from the University of Delhi, post-graduate diplomas in hospital and health management, disaster preparedness, and rehabilitation, and an MBA in healthcare administration from the University of Delhi.
He began his career as a medical officer in 1988 and retired from the Ministry of Health and Family Welfare in 2021. Before joining Molbio, he served as Deputy Director General at the National TB Elimination Programme and Regional Director at The Union South-East Asia office of the International Union Against Tuberculosis and Lung Disease.
Amol Narayan Lone is the President and Chief Financial Officer of Molbio. Having joined on June 5, 2024, Amol oversees and manages the organization’s financial operations. With a bachelor’s in commerce from the University of Pune and an MBA from the Institute of Chartered Financial Analysts of India University, Tripura, Amol is an associate member of the Institute of Chartered Accountants of India.
With 18 years of experience in financial operations and planning, he previously worked with Henkel Adhesives Technologies India, Watson Pharma, and Fermenta Biotech, among other roles.
A seasoned professional with extensive experience in global markets, Mr. Sumit Mitra leads Molbio’s international sales.
He plays a significant role in ensuring the organization’s cutting-edge technology solutions reach every corner of the world where they are needed
Mr. Mitra holds a Master’s in Science (Biochemistry) from North Eastern Hill University, India, and has more than 33 years of industry experience.
Before Molbio, he served as the Marketing Manager at Tulip Diagnostics Private Limited, where he managed sales and marketing functions.
Indraneil Borkakoty has been the Vice President of Molbio since May 15 th 2024 and oversees the Investor Relations and Merger and Acquisition functions of the organisation. With a bachelor’s degree in arts from the University of Delhi and a master’s degree in Management from the International Management Institute, New Delhi, Indraneil has over 25 years of experience in capital markets and mergers and acquisitions.
Before joining Molbio, he worked with Lazard, KPMG, Kotak, Nomura Holdings, and Jefferies Group. Mr. Borkakoty plays a critical role in driving strategic investments and fostering collaborations to ensure Molbio’s sustained growth.
Reeti Desai Hobson is Vice President, Global Health Programs and Partnerships at Molbio Diagnostics. She supports the introduction and scale-up of global point-of-care diagnostics, while focusing on strategic growth, thought leadership, business development, and innovative public-private partnerships to maximize impact at the last mile.
A molecular biologist by training, Reeti holds a graduate degree in international public health from New York University and an undergraduate in molecular biology from the University of California, San Diego.
Ms. Hobson brings more than 15 years of experience in strengthening health systems across Africa and Asia. Starting as a researcher in pharmaceuticals, she supported global clinical research programs at Quintiles/iQVIA She has since worked with multiple governments and multilateral clients, such as USAID, governments in Africa, Asia, and Central America, the UNICEF, the Global Fund, WHO, the Centers for Disease Control and Prevention (CDC); Henry Jackson Foundation, and the Human Resources Services Administration.
Before Molbio, she was the Tuberculosis Portfolio Lead at ICF International and served as the Tuberculosis Strategic Lead for USAID’s (United States Agency for International Development) Infectious Disease Detection and Surveillance (IDDS) project.
Arun Kumar Jha is an Independent Director on the Board of Molbio. A retired officer of the Indian Economic Service, Mr. Jha brings 36 years of experience in the public sector, including his tenure as a Principal Advisor in the Department of Agriculture and Farmers Welfare, Ministry of Agriculture and Farmers Welfare.
With a graduate degree in economics and law, a master’s in science, and a PhD in economics, Mr Jha is currently the Chancellor of the National Institute of Advanced Manufacturing Technology (NIAMT) in Ranchi, Jharkhand.
Balram Bhargava is an Independent Director on the Board of Molbio. He holds a bachelor’s degree in medicine and surgery from the University of Lucknow and a doctorate in medicine and cardiology from the University of Lucknow.
A leader in public health with over 35 years of experience in medical research and health system strengthening, Dr. Bhargava worked as the Director General of the Indian Council of Medical Research, as a Professor of cardiology at the All-India Institute of Medical Sciences, New Delhi, and Secretary of Department of Health Research, Ministry of Health and Family Welfare. He is also on the board of Indian pharmaceutical giant Cipla Limited.
Nupur Garg is an Additional Independent Director on the Board of Molbio. She holds an MBA from the Massachusetts Institute of Technology and is an associate member of the Institute of Chartered Accountants of India. With extensive experience in finance and private equity, Nupur serves as an independent director on the boards of Kids Clinic India Limited, Kerala Infrastructure Fund Management Limited, and Edelweiss Real Assets Managers Limited.
Previously, she has advised Triple Jump B.V. and worked with Discovery Communications India and the International Finance Corporation. She was also an independent member of the investment committee for the NIIF Fund of Funds-1, managed by the National Investment and Infrastructure Fund Limited.
Nupur has received several accolades, including the ‘Business Excellence and Innovative Best Practices – Academia Award 2019’ from the New Delhi Institute of Management. She has been featured in the BW ‘VC World Most Influential Women 2022’, VCWorld ‘Most Influential Women 2023’, and VCWorld ‘Most Influential Women 2024’.
Additionally, she was included in the Forbes W-Power list of ‘Self Made Women 2020’ and the Association of International Wealth Management of India’s list of ‘India’s Top 100 Women in Finance 2019’.
Rohit M.A. is a healthcare entrepreneur, investor, and boardroom leader with over two decades of experience building and scaling category-defining businesses.
He is the Co-founder and Director of Cloudnine Group of Hospitals, India’s leading network for maternity, women, and child healthcare. From inception to scaling it into a national brand, Rohit has been instrumental in shaping Cloudnine’s growth journey, driving strategic direction, operational excellence, and investor partnerships—positioning the company for public markets.
Rohit is also the Managing Partner at PeerCapital, a next-generation early-stage venture capital fund backing bold, tech-native startups across India. With deep roots in the startup ecosystem as a founder, operator, and family office investor, he brings a unique founder-first lens to investing.
An Executive MBA alumnus of IIM Bangalore with a specialization in Entrepreneurship, Rohit is a certified corporate director and an active board member across healthcare, technology, and impact-led ventures. He has been recognized with numerous accolades, including The Economic Times 40 Under 40, and is widely regarded for his leadership, ecosystem perspective, and ability to build and back enduring ventures
Rohit Mantri is the Nominee Director of Molbio and is associated with Motilal Oswal Private Equity since 2015. He is responsible for institutional fundraising, deal sourcing, investing, monitoring and managing exits at Motilal Oswal. He focuses on businesses in the life sciences sector, and represents the existing funds on the Board of Arinna Life Sciences, Symbiotec Pharmalab, Molbio Diagnostics and Ganesh Grains. He led investments in Ganesh Grains from Fund II and in Symbiotec Pharmalab and Molbio Diagnostics from Fund III.
Prior to joining Motilal Oswal Private Equity, Mr. Mantri garnered 15 years of experience in the life sciences sector in private equity and investment banking (KPMG). At KPMG, he worked as an Associate Director in the investment banking business and was responsible for origination and execution of M&A, private equity, financial restructuring and joint venture transactions. He extensively covered pharmaceutical, chemical and healthcare companies in India and managed relationships at the promoter and senior management levels.
Mr. Mantri also advised on M&A transactions involving mid-size Indian pharma companies like Unimark Remedies, Kilitch Drugs, NBZ Pharma, Bafna Pharma as well as large multinationals like J&J, Akorn, Hikma, GSK, among others. He was also involved in Nihon Nohyaku’s (Japan) acquisition of an agro-chemicals business in India, financial restructuring of Marksans Pharma and Voltas’ (a Tata group company) joint venture transaction.
Mr. Mantri holds a Bachelor’s degree in Commerce from the University of Indore. He is a member of The Institute of Chartered Accountants of India and a qualified Company Secretary.
Ved Prakash Kalanoria is currently a Non-Executive Nominee Director of Molbio Diagnostics. He holds a bachelor’s degree in commerce from the University of Calcutta. He is a qualified chartered accountant from the Institute of Chartered Accountants of India. He is currently working with Temasek Holdings Advisors Private Limited as a director. He has over 12 years of work experience.
